It has recently been suggested that people of the Indian population who carried the codon 149 polymorphism (GAT?GGT) of P21 Waf1/Cip1 gene were more susceptible to esophageal cancer and oral cancer than the individuals without that polymorphism. Since esophageal cancer is a high incident neoplasm in China, we analysed the same codon of P21 Waf1/Cip1 in the Chinese population. Blood samples from 80 esophageal cancer patients and 80 normal blood donors were collected for DNA extraction. Methods of Polymerase Chain Reaction (PCR) and direct sequencing were used for detection of the polymorphism in codon 149 of P21 El-Deiry et al., 1993; Gujuluva et al., 1994) . The CDS of it is 495 bp distributed in exons 2 and 3, respectively. As well known, in response to DNA damage, P21
Waf1/Cip1 is a key mediator of the G0-G1 cell cycle arrest induced by tumor suppressor protein P53. Further study revealed that P21
Waf1/Cip1 also interacted with proliferating cell nuclear antigen (PCNA) to cause both G1 and G2 cell cycle arrest in P53-deficient cells (Sheikh et al., 1994; Zeng and El-Deiry, 1996; Jiang et al., 1994) . A novel polymorphism of P21 Waf1/Cip1 gene in codon 149 was found in the Indian population and was considered as a genetic susceptible marker to esophageal and oral cancers (Bahl et al., 2000; Ralhan et al., 2000) . Since PCNA binding motif is located between codon 144 -151, we became interested in this polymorphism in the Chinese population, especially in esophageal cancer patients.
One hundred and sixty blood samples were collected from 80 esophageal cancer patients (40 from Anyang area, Henan Province, one of the highest esophageal cancer incident areas in China, another 40 from sporadic cancer patients in Beijing) and 80 samples from normal controls from Anyang and Beijing. Patients and normal individuals were matched. Genomic DNA was extracted and amplified by PCR.
P21
Waf1/Cip1 exons 2 and 3 specific primers were used to amplify DNA fragments of 589 bp and 358 bp, respectively ( Figure 1 ).
Direct sequencing of the PCR products has shown that no polymorphism existed in any of those samples tested (Figure 2a -e), as reported in Bahl's study. But a polymorphism in intron 2 between exons 2 and 3 (16th base C?G) was found (Figure 2f -i) . Because it lies within intron and randomly appeared in patients and normal individuals, it may not be significant in carcinogenesis.
Racial difference was first considered as an explanation for this result, but the bioinformatics analysis revealed that there is a mistake in the definition of codon 149 and its 'polymorphism'.
The analysis of the genomic structure in human P21 Waf1/Cip1 gene was performed by the sim4 program (version 4.2) (Florea et al., 1998) , which aligned the mRNA of P21 Waf1/Cip1 gene (GenBank: XM_043412) with the human genomic sequence (GenBank: NT_007592) (Figure 3a) . The full length of the P21 Waf1/Cip1 mRNA is 2201 bp, which codes a protein of 164 amino acids from 76 to 570 bp. There are three exons in human P21 Waf1/Cip1 gene. Exon 1 and the first 5 bp of exon 2 are 5'-UTR, as well as the last 1731 bp of exon 3 is 3'-UTR. The evidence from The Human Gene Mutation Database (http://archive.uwcm.ac.uk/ uwcm/mg/cdna/266550.txt) showed that codon 149 of As described above, the three bases of codon 149 (GAT) are separated by intron 2 and distributed at the last base (position 520?G) in exon 2 and the two first bases (position 521 -2?A*T) in exon 3 (Figure 3a) . The intron 2, a 1206 bp fragment, locates between the 'G' and 'A T' of codon 149. It is interesting to note that the first two bases of intron 2 are G and T (Figure  3b -c) . If one regards the base at position 520 and the first two base of intron 2 as codon 149, it should become GGT. Actually, the novel polymorphism in codon 149 of GAT?GGT is misunderstanding of intron 2 sequence (the first 2 bp, GT) as parts of codon 149 in previous studies. P21 Waf1/Cip1 is unique among the known CDKIs. It inhibits the two different targets, the cyclin-CDK complexes and PCNA, which control cell cycle transitions and DNA replication. The human P21
Waf1/Cip1 gene is extremely conserved with 79% identity to mouse at amino acids level . Two particularly conserved regions in human P21
Waf1/Cip1 gene were found on codons 21 -60 and codons 130 -164 . The PCNA binding motif is located between codons 144 -151, which overlaps in the highly conserved regions (Chen et al., 1995; Goubin and Ducommun, 1995) . PCNA is essential for DNA replication and repair (Cayrol et al., 1998) . It is an auxiliary factor for DNA polymerase d and e and facilitates loading of the polymerases onto DNA templates and increases their activity in both DNA replication and repair (Funk et al., 1997) . When interacted with P21 Waf1/Cip1 , PCNA-dependent DNA replication is inhibited (Flores-Rozas et al., 1994) . This explains the mechanism that both G1 and G2 growth arrest induced by PCNA-dependent P21 Waf1/Cip1 . If there were any significant SNPs in the PCNA binding motif of P21 Waf1/Cip1 , the structural changes in the protein product might affect the binding between P21 Waf1/Cip1 and PCNA. As a consequence, people who carry the 'polymorphism' might be susceptible to cancer formation. However, our experimental result and bioinformatics analysis have proved that there were no SNPs among the PCNA binding motif of P21
Waf1/Cip1 in Chinese people we have surveyed, and it is not a susceptible marker to esophageal cancer.
Abbreviations CDKI, cyclin-dependent kinase inhibitor; CDS, coding regions; SNPs, single nucleotide polymorphisms; UTR, untranslated regions Waf1/Cip1 by sequencing. PCR products were purified by MultiScreen-PCR purifying plate (Millipore Company USA). Sequencing of PCR product was performed by ABI 3700 DNA sequencer (Perkin-Elmer). Sequencing primers were designed by Primer Premier (version 5.0). Exon 2 sequencing primer: 5'-TGG CCT GCC CAA GCT CTA CC-3', Exon 3 sequencing primer: 5'-CCC CTC AAG AGA CAG AGT GG-3'. The chromatograms were base-called with phred (version 0.990722) (Ewing et al., 1998) , assembled with Phrap (version 0.990329), scanned by PolyPhred (version 3.5) (Nickerson et al., 1997) , and the results were viewed with Consed (version 9.0) (Gordon et al., 1998) . DNA polymorphisms within the sequencing traces were identified by PolyPhred. 
